98 related articles for article (PubMed ID: 22002635)
1. In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Gebhardt E; Eberlein B; Przybilla B; Gilbertz KP; Placzek M
Acta Derm Venereol; 2012 Mar; 92(2):208-10. PubMed ID: 22002635
[No Abstract] [Full Text] [Related]
2. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
Toxicol Appl Pharmacol; 1996 Feb; 136(2):317-23. PubMed ID: 8619239
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
4. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
Kanayama S
Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
[TBL] [Abstract][Full Text] [Related]
5. Influence of H2-receptor- and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism.
Scheuch E; Walter R; Hadasová E; Amon I; Siegmund W
Pharmazie; 1996 Jul; 51(7):493-7. PubMed ID: 8774841
[TBL] [Abstract][Full Text] [Related]
6. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
7. Heart allograft rejection in rats triggered by H2 inhibitors.
Olausson M; Wramner L; Blohmé I; Mjörnstedt L
Transplant Proc; 1997 Nov; 29(7):3127-8. PubMed ID: 9365695
[No Abstract] [Full Text] [Related]
8. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
Yukawa K; Yukawa E
Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
[TBL] [Abstract][Full Text] [Related]
9. Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
Fernández-Fernández FJ; Sesma P; Caínzos-Romero T; Ferreira-González L
Neth J Med; 2010 Oct; 68(10):329-30. PubMed ID: 21071783
[No Abstract] [Full Text] [Related]
10. Head-column field-amplified sample stacking in capillary electrophoresis for the determination of cimetidine, famotidine, nizatidine, and ranitidine-HCl in plasma.
Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
Electrophoresis; 2001 Aug; 22(13):2717-22. PubMed ID: 11545397
[TBL] [Abstract][Full Text] [Related]
11. Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients.
Takahashi N; Miura M; Niioka T; Sawada K
Cancer Chemother Pharmacol; 2012 Apr; 69(4):999-1004. PubMed ID: 22147077
[TBL] [Abstract][Full Text] [Related]
12. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
14. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
[TBL] [Abstract][Full Text] [Related]
15. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
16. Comparison tables: H2-receptor antagonists and PPIs.
Med Lett Drugs Ther; 2022 Apr; 64(1647):e56-e57. PubMed ID: 35348553
[No Abstract] [Full Text] [Related]
17. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
Ashiru DA; Patel R; Basit AW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):235-40. PubMed ID: 18006395
[TBL] [Abstract][Full Text] [Related]
18. Effects of histamine H2-antagonists on pre- and post-natal development in the rat.
Freeman P; Sturman G; Suhonen AM; Meade HM; Seeley NA
Inflamm Res; 1997 Mar; 46 Suppl 1():S55-6. PubMed ID: 9098763
[No Abstract] [Full Text] [Related]
19. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
20. Bone remodeling after administration of proton pump (H+/K+-ATPase) inhibitors and alendronate in ovariectomized rats.
Pytlik M; Cegieła U; Nowińska B; Folwarczna J; Sliwiński L; Kaczmarczyk-Sedlak I; Pytlik M; Bolek D; Korzeniowska H
Acta Pol Pharm; 2012; 69(1):113-20. PubMed ID: 22574514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
